Healthcare Industry News: non-invasive patient monitor
News Release - September 1, 2009
Leading UK Hospital First to Install FORE-SIGHT Absolute Cerebral Oximetry
BRANFORD, Conn., Sept. 1-- (Healthcare Sales & Marketing Network) -- CAS Medical Systems, Inc. (Nasdaq:CASM ) announced today that it has successfully completed the first installation of FORE-SIGHT(r) Absolute Cerebral Oximeters in the UK with the purchase of five monitors by the Lancashire Cardiac Centre in Blackpool, Lancashire UK for use in its Operating Rooms and Intensive Care Units."The decision to convert to FORE-SIGHT Cerebral Oximetry was based on evaluating what was best for our patients," said Dr. Mike Hartley, Consultant Cardiothoracic Anaesthetist at the Lancashire Cardiac Centre. "It is vitally important for us to incorporate technologies that will help us to improve patient care. With FORE-SIGHT, we believe that we will be able to better detect and resolve problems with cerebral perfusion before they can negatively impact patients."
CASMED's President and CEO, Andrew E. Kersey, stated, "We are delighted that, after evaluating all available technologies, the Lancashire Cardiac Centre chose FORE-SIGHT as a standard-of-care in their facility to non-invasively measure brain oxygen saturation during critical procedures. FORE-SIGHT's accuracy and performance will allow the Lancashire Cardiac Centre to better monitor, manage and treat patients at risk for decreased cerebral oxygen saturation."
The Lancashire Cardiac Centre provides heart and lung treatment for the people of Lancashire, Cumbria and beyond, performing 1200 adult cardiothoracic surgery cases per year. The hospital will be the co-host of the Autumn 2009 meeting of the Association of Cardiothoracic Anaesthetists.
About CASMED(r) -- Monitoring What's Vital
CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter was the first cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition.
The Company's product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Cerebral Oximeter; the bedside patient monitoring line of vital signs and cardio-respiratory monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.
For further information regarding CAS Medical Systems, Inc., visit the Company's website at www.casmed.com.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, the impact of actions and events involving key customers and vendors, and other risks detailed in the Company's Form 10-K for the year ended December 31, 2008 and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.
Source: CAS Medical Systems
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
